Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology Claudia A. DumitruKatrin MosesSven Brandau Review 13 June 2012 Pages: 1155 - 1167
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy Tonia MazzarellaValeria CambiaghiCristina Maccalli Original article Open access 30 December 2011 Pages: 1169 - 1182
FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer Paul SalamaColin StewartBarry Iacopetta Original article 31 December 2011 Pages: 1183 - 1190
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors Sofia EberstålWiaam BadnPeter Siesjö Original Article 03 January 2012 Pages: 1191 - 1199
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding Leticia Huergo-ZapicoAna P. Gonzalez-RodriguezSegundo Gonzalez Original Article 04 January 2012 Pages: 1201 - 1210
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy Hiroki YoshiokaShinji YamamotoKeigo Endo Original article 06 January 2012 Pages: 1211 - 1220
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion Marie Klinge BrimnesAnne Ortved GangSine Reker Hadrup Original article 12 January 2012 Pages: 1221 - 1231
Rituximab-induced direct inhibition of T-cell activation Dina StroopinskyTamar KatzIrit Avivi Original article 17 January 2012 Pages: 1233 - 1241
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer Emilia AnderssonLisa VillabonaGiuseppe V. Masucci Original Article 19 January 2012 Pages: 1243 - 1253
Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways Ming LiDeborah A. KnightTrina J. Stewart Original Article 24 January 2012 Pages: 1255 - 1268
CAR T cells transform to trucks: chimeric antigen receptor–redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer Markus ChmielewskiHinrich Abken Focussed Research Review 25 January 2012 Pages: 1269 - 1277
Harnessing human plasmacytoid dendritic cells as professional APCs Jurjen TelAnne M. van der LeunI. Jolanda M. de Vries Focussed Research Review Open access 01 February 2012 Pages: 1279 - 1288
The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase Mads Hald Andersen Focussed Research Review Open access 03 March 2012 Pages: 1289 - 1297
Re-purposing cancer therapeutics for breast cancer immunotherapy Leisha A. Emens Focussed Research Review 28 March 2012 Pages: 1299 - 1305
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers Kelly BarriosEsteban Celis Focussed Research Review 22 April 2012 Pages: 1307 - 1317
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC) Suzanne Ostrand-RosenbergPratima SinhaChristopher Ecker Focussed Research Review 01 May 2012 Pages: 1319 - 1325
The expression, function, and clinical relevance of B7 family members in cancer Barbara SeligerDagmar Quandt Focussed Research Review 14 June 2012 Pages: 1327 - 1341
Innate immune sensing of cancer: clues from an identified role for type I IFNs Thomas F. GajewskiMercedes B. FuertesSeng-Ryong Woo Focussed Research Review 22 June 2012 Pages: 1343 - 1347
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10–13 October 2011, Copenhagen, Denmark Tania KøllgaardJoost H. van den BergPer thor Straten Meeting Report Open access 05 February 2012 Pages: 1349 - 1353
